Literature DB >> 6496284

Clinical effects of digoxin on sinus node and atrioventricular node function after pharmacologic autonomic blockade.

P Alboni, N Shantha, L Filippi, R Pirani, S Preziosi, A M Tomasi, A Masoni.   

Abstract

The effects of digoxin on sinus node and atrioventricular (AV) node function were studied in 18 patients (mean age 53.6 years) with normal intrinsic heart rates. Electrophysiologic testing was performed both during basal state and after autonomic blockade with propranolol and atropine. Full digitalization was achieved by intravenous administration of digoxin (0.02 mg/kg) given in three divided doses over a 24-hour period. The following day, after a basal recording, autonomic blockade was again induced and the study was repeated. During basal state, digoxin significantly prolonged the sinus cycle length (SCL) (p less than 0.01) and the AH interval (p less than 0.01). However, when the intrinsic sinus node functions were compared (i.e., the values obtained after autonomic blockade), digoxin did not produce significant changes in intrinsic SCL, corrected sinus node recovery time, and sinoatrial conduction time. No significant changes were noted even in the intrinsic AH interval and AV nodal refractory periods. These findings suggest that: (1) intravenous administration of digoxin in therapeutic doses does not produce any depression of the intrinsic functions of the sinus node and AV node; and (2) the depressant effects induced by digoxin during basal state appear to be mediated through the autonomic nervous system.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6496284     DOI: 10.1016/0002-8703(84)90750-6

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  5 in total

1.  Case files of the medical toxicology fellowship of the California poison control system-San Francisco: calcium plus digoxin-more taboo than toxic?

Authors:  Christian P Erickson; Kent R Olson
Journal:  J Med Toxicol       Date:  2008-03

2.  Digitalis: where are we now?

Authors:  D A Chamberlain
Journal:  Br Heart J       Date:  1985-09

Review 3.  Pharmacologic Rate versus Rhythm Control for Atrial Fibrillation in Heart Failure Patients.

Authors:  Ioanna Koniari; Eleni Artopoulou; Dimitrios Velissaris; Virginia Mplani; Maria Anastasopoulou; Nicholas Kounis; Cesare de Gregorio; Grigorios Tsigkas; Arun Karunakaran; Panagiotis Plotas; Ignatios Ikonomidis
Journal:  Medicina (Kaunas)       Date:  2022-05-30       Impact factor: 2.948

Review 4.  Drug effects on the sinus node. A clinical perspective.

Authors:  N J Linker; A J Camm
Journal:  Cardiovasc Drugs Ther       Date:  1988-07       Impact factor: 3.727

Review 5.  Atrial fibrillation in heart failure: drug therapies for rate and rhythm control.

Authors:  Rafik Tadros; Paul Khairy; Jean L Rouleau; Mario Talajic; Peter G Guerra; Denis Roy
Journal:  Heart Fail Rev       Date:  2014-05       Impact factor: 4.214

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.